Myeloproliferative Neoplasms Clinical Trial
A Mobile Intervention (txt4TKI) for the Improvement of Tyrosine Kinase Inhibitor Management in Patients With Chronic Myeloid Leukemia
This trial studies the feasibility and acceptability of a mobile intervention called txt4TKI for the improvement of tyrosine kinase inhibitor management in patients with chronic myeloid leukemia. Tyrosine kinase inhibitors (TKI) are associated with numerous potential side effects, including a decrease in bone marrow activity (myelosuppression), nausea, diarrhea, fatigue, and soft-tissue swelling (edema), especially in the face and lower legs, which are the primary reasons for patients to discontinue TKI medication. Using a mobile text messaging (TXT) intervention that emphasizes the importance of TKI compliance may improve TKI adherence in patients with chronic myeloid leukemia.
PHASE 1: Patients diagnosed with chronic myeloid leukemia
PHASE 1: Initiated tyrosine kinase inhibitors therapy for a year
PHASE 1: Able to read and understand English
PHASE 1: Able to provide informed consent
PHASE 1: Have a mobile phone with TXT capability
PHASE 1: Know how to use TXT
PHASE 2: Patients diagnosed with chronic myeloid leukemia in the chronic phase
PHASE 2: Starting tyrosine kinase inhibitors therapy or has been on tyrosine kinase inhibitors with anticipation of at least 6 month duration of use
PHASE 2: Able to read and understand English
PHASE 2: Able to provide informed consent
PHASE 2: Have a mobile device with TXT capability
PHASE 2: Willing to use a wireless pill bottle during study for 6 months
PHASE 2: Know or willing to learn how to use TXT
• Cognitive impaired document in the electronic medical record (EMR)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Philadelphia Pennsylvania, 19107, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.